COMMUNIQUÉS West-GlobeNewswire

MEDIROM Rehab Solutions Inc. Acquires Rehabilitation Centers from Y’s, Inc.

07/10/2024 - 22:00

TOKYO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“Medirom” or the “Company”) is pleased to announce that it is capitalizing on its extensive experience operating wellness [...]

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

07/10/2024 - 19:00

Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 7 octobre 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

07/10/2024 - 19:00

Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 7 octobre 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

07/10/2024 - 19:00

Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 7 octobre 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]

EssilorLuxottica: Third-Quarter 2024 Revenue Conference Call Invitation

07/10/2024 - 18:00

Third-Quarter 2024 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our Third-Quarter 2024 Revenue [...]

EssilorLuxottica: Third-Quarter 2024 Revenue Conference Call Invitation

07/10/2024 - 18:00

Third-Quarter 2024 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our Third-Quarter 2024 Revenue [...]

Safe Group et SpineUp au NASS 2024 : des synergies pour accélérer le déploiement des solutions

07/10/2024 - 18:00

Safe Group et SpineUp au NASS 2024 : des synergies pour accélérer le déploiement des solutions Fleurieux-sur-l’Arbresle - France - le 7 octobre 2024 à 18h . Safe SA (FR001400F1V2 – ALSAF), spécialiste dans la conception [...]

Breakthrough in Brain–Computer Interface Technology: A New Era of Neural Decoding at the Society for Neuroscience Annual Meeting, Neuroscience 2024

07/10/2024 - 17:05

Precision Neuroscience’s Cortical Surface Array unlocks an unprecedented view of neural patterns, poised to revolutionize neural decoding NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Researchers shared groundbreaking [...]

CytoDyn Announces Abstract that Highlights Leronlimab’s Potential in Mediating ART-Free Viral Control in Infant Rhesus Macaques

07/10/2024 - 17:05

Abstract to be presented at the 5 th annual HIV Research for Prevention Conference Study results highlight potential for treatment VANCOUVER, Washington, Oct. 07, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (" [...]

Colateral completes acquisition of Turbyne creating the first retail media operating system designed for in-store, that integrates with all channels and partners

07/10/2024 - 17:00

TRURO, United Kingdom, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Colateral , a retail marketing platform, announced today the acquisition of Turbyne, a Delaware-based provider of omnichannel Retail Media capabilities, in a [...]

Route 92 Medical Files Patent Infringement Suit Against Q’Apel Medical

07/10/2024 - 14:33

SAN MATEO, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today filed a [...]

Inozyme Pharma Announces Appointment of Biopharmaceutical Commercial Leader Erik Harris to its Board of Directors

07/10/2024 - 14:30

BOSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company developing innovative therapeutics for rare diseases that affect [...]

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

07/10/2024 - 14:30

HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, is pleased [...]

GRI Bio to Present at the 22nd International Colloquium on Lung and Airway Fibrosis

07/10/2024 - 14:30

LA JOLLA, CA, Oct. 07, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the [...]

Prenetics Announces Second Quarter 2024 Financial Results

07/10/2024 - 14:30

Cost Optimization Boosted Gross Margin by 21.7% YoY in H1 2024 Enters U.S. Health Market in October with IM8, a New Health and Wellness Brand Re-affirms Revenue Target to Exceed US$33 million for FY 2024 CHARLOTTE, N.C [...]

Mass General Hospital researcher Gary Ruvkun honored with 2024 Nobel Prize

07/10/2024 - 14:24

Physiology or Medicine Prize award honors discovery of small regulatory RNAs Boston, MA, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Media notice: a press conference with Dr. Ruvkun will be held at the MGH Richard B. Simches [...]

Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology

07/10/2024 - 14:15

DUBLIN, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today [...]

IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

07/10/2024 - 14:05

LAWRENCEVILLE, N.J., Oct. 07, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN ) (the “Company”), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today announced that the [...]

ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society

07/10/2024 - 14:00

LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it [...]